HALIA THERAPEUTICS INC

Business Summary
Halia Therapeutics Inc is a United States-based clinical-stage biopharmaceutical company. The Company develops treatments for chronic inflammatory and neurodegenerative diseases. It focuses on resilience-driven, inflammation-targeted therapies, using genetic insights and artificial intelligence (AI) to create a pipeline of small-molecule drugs. Its candidates, such as HT-6184 (Ofirnoflast) and HT-4253, are in phases of clinical trials for conditions including myelodysplastic syndrome (MDS) and neuroinflammation.
Country of Incorporation
United States of America
Incorporation Date
2017-08-30
Business Sector
Pharmaceuticals & Medical Research
Company Address
3900 N. Traverse Mountain Blvd, Suite 100
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Find out more
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.

NEWS ON THIS COMPANY

Find companies

ZAWYA NEWSLETTERS

Get insights and exclusive content from the world of business and finance that you can trust, delivered to your inbox.

Subscribe to our newsletters: